Two new appointments at Kyowa Hakko USA

Kyowa is the maker of branded ingredients including Cognizin Citicoline, Pantesin Pantethine and Setria Glutathione, as well as Sustamine L-alanyl-L-glutamine

Leo R. Cullen promoted to President and CEO

Leo Cullen, former Executive Vice President of Kyowa Hakko USA (Kyowa) accepts the position of President and CEO for Kyowa Hakko USA. Leo joined Kyowa in 2007 as Vice President of Sales and Marketing and has served as the Executive Vice President since 2012. He has more than 25 years of experience in the pharmaceutical and nutraceutical ingredient businesses.

Cullen will continue to be based out of the New York City office, where his responsibilities will including growing the North and South American pharmaceutical, dietary supplement and cosmetic business areas. Cullen will be responsible for all aspects of the Kyowa Hakko USA's business growth and development.

D. Christopher Nolte promoted to Vice President of Nutritional Sales

D. Christopher Nolte, former Director of Nutritional Sales of Kyowa Hakko USA accepts the position of Vice President of Nutritional Sales for Kyowa Hakko USA. Chris joined the company in 2008 and has served as Director of Sales since 2014. He has more than 20 years of nutritional ingredient sales experience.

Nolte will continue his responsibilities in growing the North and South American dietary supplement and cosmetic business.

You may also like

Ingredients

Kyowa Hakko’s IMMUSE powers Sensilab’s new IMMUNOFAR Biotic for enhanced immune support

The incorporation of IMMUSE facilitates the strengthening of pDC functionality, promoting a healthy immune system
Active Nutrition

Karma Energy Water featuring Cognizin citicoline at Natural Products Expo West

The novel energy drink will be available to sample in three natural flavours
Dietary supplements

Kyowa Hakko Bio celebrates opening of expanded Cognizin citicoline manufacturing facility in Hofu, Japan

Kyowa Hakko Bio and Kyowa Hakko USA, Inc., a subsidiary of Kirin Holdings, is thrilled to announce the grand opening of its expanded citicoline manufacturing facilities at the Kyowa Hakko Bio Yamaguchi Production Center
Ingredients

Kyowa Hakko Bio’s 6’-sialyllactose sodium salt receives novel food approval in the EU

Kyowa Hakko Bio, a subsidiary of Kirin Holdings Company, is pleased to announce that its 6’-sialyllactose sodium salt (6’-SL), a human milk oligosaccharide (HMO), has been approved as a novel food by the European Commission in the European Union
Ingredients

First in Europe: innovative vision postbiotic EYEMUSE combats digital eye fatigue

Supersmart, a leading name in the field of dietary supplements and nutritional products, is proud to announce the launch of its groundbreaking product: Vision Postbiotic EYEMUSE
Ingredients

Kyowa Hakko's Cognizin Citicoline turns 20 at SupplySide West

Located at booth 4165, Kyowa will be hosting a "special event" at SSW, with its branded ingredient Cognizin being its focal point
Manufacturing

Kyowa Hakko launches postbiotic IMMUSE in Mexico

Partnering with manufacturer Quifaest, Kyowa Hakko has celebrated the launch of its postbiotic named IMMUSE at a product launch in Mexico
Subscribe now